Evidence-based management of vitiligo: summary of a Cochrane systematic review
- PMID: 26686510
- DOI: 10.1111/bjd.14356
Evidence-based management of vitiligo: summary of a Cochrane systematic review
Abstract
Vitiligo affects around 1% of the world's population. Despite it being relatively common, there is still no effective treatment. The objective of this study was to update the Cochrane systematic review of randomized clinical trials (RCTs) to evaluate the efficacy of treatments for vitiligo. We carried out searches of a range of databases to October 2013 for RCTs of interventions for vitiligo regardless of language or publication status. At least two reviewers independently assessed study eligibility and methodological quality and extracted data using data extraction forms approved by the Cochrane Skin Group. Our primary outcomes of interest were quality of life, > 75% repigmentation and adverse effects. We retrieved 96 studies, of which 39 were new studies, with an overall total of 4512 participants. Repigmentation was assessed in all studies, although only five reported on all three of our primary outcomes. Regarding our two secondary outcomes, six studies measured cessation of spread but none assessed long-term permanence of repigmentation at 2 years' follow-up. Most of the studies evaluated combination treatments, which generally showed better repigmentation than monotherapies. Of the new studies, seven were surgical interventions. The majority of the studies had fewer than 50 participants. The quality of the studies was poor to moderate at best. Very few studies specifically included children or participants with segmental vitiligo. Five years after the last update of this review, there are still important variations in study design and outcome measures in clinical trials for vitiligo, limiting the evidence for the efficacy of different therapeutic options. The best evidence from individual trials showed short-term benefit from topical corticosteroids and various forms of ultraviolet radiation combined with topical preparations. Long-term follow-up and patient-rated outcomes should be incorporated into study design, and more studies should assess psychological interventions.
© 2015 British Association of Dermatologists.
Similar articles
-
Interventions for vitiligo.Cochrane Database Syst Rev. 2015 Feb 24;2015(2):CD003263. doi: 10.1002/14651858.CD003263.pub5. Cochrane Database Syst Rev. 2015. PMID: 25710794 Free PMC article. Review.
-
Interventions for vitiligo.Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003263. doi: 10.1002/14651858.CD003263.pub4. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2015 Feb 24;(2):CD003263. doi: 10.1002/14651858.CD003263.pub5 PMID: 20091542 Updated. Review.
-
Therapeutic interventions for vitiligo.J Am Acad Dermatol. 2008 Oct;59(4):713-7. doi: 10.1016/j.jaad.2008.06.023. J Am Acad Dermatol. 2008. PMID: 18793940 Review.
-
Interventions for vitiligo.Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003263. doi: 10.1002/14651858.CD003263.pub3. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003263. doi: 10.1002/14651858.CD003263.pub4 PMID: 16437451 Updated. Review.
-
Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.Photodermatol Photoimmunol Photomed. 2017 Jan;33(1):22-31. doi: 10.1111/phpp.12277. Epub 2016 Nov 23. Photodermatol Photoimmunol Photomed. 2017. PMID: 27696531 Review.
Cited by
-
Psychometric Properties and Meaningful Change Thresholds of the Vitiligo Area Scoring Index.JAMA Dermatol. 2024 Oct 30:e244534. doi: 10.1001/jamadermatol.2024.4534. Online ahead of print. JAMA Dermatol. 2024. PMID: 39475960 Free PMC article.
-
Effectiveness of fractional erbium-YAG laser, microneedling, platelet-rich plasma in localized stable vitiligo patients: randomized clinical trial.Arch Dermatol Res. 2024 Jun 15;316(7):399. doi: 10.1007/s00403-024-03035-8. Arch Dermatol Res. 2024. PMID: 38878236 Free PMC article. Clinical Trial.
-
Gender differences in quality of life of vitiligo patients attending a tertiary care center.Ind Psychiatry J. 2024 Jan-Jun;33(1):147-153. doi: 10.4103/ipj.ipj_74_23. Epub 2023 Oct 4. Ind Psychiatry J. 2024. PMID: 38853817 Free PMC article.
-
308 nm excimer laser and tacrolimus ointment in the treatment of facial vitiligo: a systematic review and meta-analysis.Lasers Med Sci. 2024 Mar 8;39(1):90. doi: 10.1007/s10103-024-04033-y. Lasers Med Sci. 2024. PMID: 38456924 Review.
-
Understanding of Pathomechanisms and Clinical Practice for Vitiligo.Ann Dermatol. 2023 Oct;35(5):333-341. doi: 10.5021/ad.23.065. Ann Dermatol. 2023. PMID: 37830414 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
